Industry News
Pain And Nausea In Cancer Patients Reduced By Touch Therapy
Jun 29, 2012
Just one session of Jin Shin Jyutsu, an ancient form of touch therapy similar to acupuncture in philosophy achieved a considerable improvement in side effects of cancer treatment. Jennifer Bradley, a Jin Shin Jyutsu integrative practitioner from the University of Kentucky Markey Cancer Center presented the new study at the 2012 Markey Cancer Center Research Day... Read More
Mammogram Rates In U.S Have Dropped
Jun 29, 2012
According to a Mayo Clinic analysis, the rate of women in their 40s who have preventive mammographies has fallen by almost 6% nationwide since the U.S. Preventive Services Task Force (USPSTF) recommended against routine mammograms for women in this age group. Although small, this decrease is nevertheless significant since the release of these controversial guidelines. Nilay Shah, Ph.D... Read More
Warfarin Patients Who Have A Stroke - Outcomes With Anti-Clotting Agents
Jun 29, 2012
A study in the June 27 edition of JAMA reports that patients treated with warfarin (with an INR 1.7 or less) who had an acute ischemic stroke were not linked to a higher risk of symptomatic intracranial hemorrhage when using intravenous tissue plasminogen activator (tPA) compared with patients who were not treated with warfarin as standard treatment... Read More
Regulation Of Telomerase In Stem Cells And Cancer Cells
Jun 29, 2012
Scientists at the Max Planck Institute of Immunobiology and Epigenetics in Freiburg have gained important insights for stem cell research which are also applicable to human tumours and could lead to the development of new treatments... Read More
FDA Approves Bloodstream Bacteria Test
Jun 29, 2012
A new test for 12 different types of bacteria that cause bloodstream infections has been approved by the FDA. The test is much faster than current laboratory techniques, and can pickup on signs of bacterial growth within hours of the infection starting... Read More
Survival In Hodgkin Lymphoma Patients Dramatically Improved By New Drug
Jun 29, 2012
A new cancer drug with remarkably few side effects is dramatically improving survival in Hodgkin lymphoma patients who fail other treatments and are nearly out of options. Loyola University Medical Center oncologist Scott E. Smith, MD, PhD presented survival data for the drug, brentuximab vedotin (Adcetris®), at the 17th Congress of the European Hematology Association... Read More
New Cancer Stem Cell Mechanism Identified
Jun 29, 2012
Scientists at Queen Mary, University of London have uncovered a link between two genes which shows how stem cells could develop into cancer. The research, published in the online journal PLoS ONE, found a novel mechanism which could be the catalyst for stem cells changing into a tumour... Read More
HPV Vaccine In India Controversial
Jun 28, 2012
A new study by researchers at Queen Mary, University of London and the University of Edinburgh, and published in the Journal of the Royal Society of Medicine, questions a trial which took place in India, regarding the HPV vaccine... Read More
FDA Approves Bloodstream Bacteria Test
Jun 28, 2012
A new test for 12 different types of bacteria that cause bloodstream infections has been approved by the FDA. The test is much faster than current laboratory techniques, and can pickup on signs of bacterial growth within hours of the infection starting... Read More
FDA Approves Bloodstream Bacteria Test
Jun 28, 2012
A new test for 12 different types of bacteria that cause bloodstream infections has been approved by the FDA. The test is much faster than current laboratory techniques, and can pickup on signs of bacterial growth within hours of the infection starting... Read More
Previous Page Next Page